Lung Cancer Management
Volume 13, 2024 - Issue 1
Open access
325
Views
0
CrossRef citations to date
0
Altmetric
Short Communication
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis
Jon Lykkegaard Andersen1 Department of Oncology, Herlev & Gentofte University Hospital, DK-2730, Herlev, DenmarkView further author information
, Jakob Sidenius Johansen1 Department of Oncology, Herlev & Gentofte University Hospital, DK-2730, Herlev, Denmark;12 Present address: Employment with Dept. of Oncology, Herlev & Gentofte University hospital, DK-2730, Herlev, Denmark, Denmark ended during the writing of the articleView further author information
, Edyta Maria Urbanska2 Department of Oncology, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark
https://orcid.org/0000-0002-4578-9346View further author information
Peter Meldgaard3 Department of Oncology, Aarhus University Hospital, DK-8000, Aarhus, DenmarkView further author information
, Peter Hjorth-Hansen4 Department of Oncology, Aalborg University Hospital, DK-9000, Aalborg, DenmarkView further author information
, Charlotte Kristiansen5 Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, DK-7100, Vejle, DenmarkView further author information
, Miroslaw Stelmach6 Department of Oncology, Næstved Hospital, DK-4700, Næstved, DenmarkView further author information
, Eric Santoni-Rugiu7 Department of Pathology, Rigshospitalet, Copenhagen University Hospital, DK-2100, Copenhagen, Denmark
https://orcid.org/0000-0002-2283-3535View further author information
Maiken Parm Ulhøi3 Department of Oncology, Aarhus University Hospital, DK-8000, Aarhus, DenmarkView further author information
, Betina Højgaard8 VIVE, Copenhagen, Denmark (The Danish Center for Social Science Research), DK-1052, Copenhagen, Denmark;13 Present address: Steno Diabetes Center, DK-2730, Herlev, DenmarkView further author information
, Morten Sall Jensen9 VIVE, Aarhus, Denmark (The Danish Center for Social Science Research), DK-8230, Åbyhøj, Denmark;14 Present address: Novo Nordisk, Søborg, DK-2860, DenmarkView further author information
, Anders Bondo Dydensborg10 Takeda Pharma A/S, Delta Park 45, DK-2665, Vallensbæk Strand, DenmarkCorrespondence[email protected]
View further author information
, View further author information
Christina Dünweber10 Takeda Pharma A/S, Delta Park 45, DK-2665, Vallensbæk Strand, DenmarkView further author information
& Karin Holmskov Hansen11 Department of Oncology, Odense University Hospital, DK-5000, Odense, Denmark
https://orcid.org/0009-0000-7619-8779View further author information
Article: LMT68
|
Received 13 Oct 2024, Accepted 21 Feb 2024, Published online: 13 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.